Status:
UNKNOWN
Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Acromegaly
Eligibility:
All Genders
18-100 years
Brief Summary
The diagnosis and the follow-up of acromegalic patients are based on the mesurement of Growth hormone (GH) and IGF1 rates. However, the literature described some cases of patient for whom the investig...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Acromegaly followed up in one of the center (Montpellier, Nimes or Béziers hospital, independent endocrinologist) between 2010 and 2021
- Age over 18 years old
- Measurement of GH and IGF1 rates at the last visit control available
- Exclusion criteria:
- Lost to follow-up
- Status about complications related to acromegaly unknown
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04860037
Start Date
January 1 2010
End Date
December 1 2022
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295